0001387131-23-009025.txt : 20230829 0001387131-23-009025.hdr.sgml : 20230829 20230728170318 ACCESSION NUMBER: 0001387131-23-009025 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 CORRESP 1 filename1.htm

Adamis Pharmaceuticals Corporation

11683 El Camino Real, Suite 300

San Diego, CA 92103

 

July 28, 2023

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

 

Re:        

Adamis Pharmaceuticals Corporation

Registration Statement on Form S-3 (No. 333-273233)

Filed on July 13, 2023

Withdrawal of Request for Acceleration

 

 

To Whom it May Concern:

Adamis Pharmaceuticals Corporation (the "Company") hereby requests the withdrawal of our request for acceleration, dated July 26, 2023, of the effective date of the above referenced registration statement as amended (the “Registration Statement”) (File No. 333-273233) that was requested to become effective at 9:00 a.m. Eastern Time, on July 28, 2023, or as soon thereafter as practicable. We hereby respectfully withdraw this acceleration request at this time. Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact Kevin Kelso at Weintraub Tobin, our counsel, at (916) 558-6110.

 

Very truly yours,

 

 

Adamis Pharmaceuticals Corporation

 

By:       

/s/ David J. Marguglio

David J. Marguglio

President